Clinical Trials Browser

Phase 2 × Terminated × Neoplasm, Residual × Clear all

NCT04785547 2024-01-16

ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04044560 2022-02-21

OZM-097

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01158885 2021-10-26

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Phase 2 Terminated

2 enrolled 7 charts

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02767934 2020-08-20

Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia

Phase 2 Terminated

12 enrolled 12 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01392170 2015-05-04

Pegasys in Patients With Chronic Myeloid Leukemia (CML)

Phase 2 Terminated

2 enrolled 3 charts

MyeloidOther hematologic neoplasm

Leukemia, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT00172068 2009-12-23

MRD-1

Phase 2 Terminated

Neoplasm, Residual